Glenmark Pharma, OMRON Healthcare India Partners To Combat Hypertension Ignorance Among Young Adults in India

India Pharma Outlook Team | Wednesday, 02 August 2023

 India Pharma Outlook Team

Glenmark Pharmaceuticals Limited (Glenmark), a leading, integrated, research-led global pharmaceutical company, has partnered with OMRON Healthcare India, the Indian arm of the Japanese global leader in home blood pressure monitoring and solutions for cardiovascular disease management, to raise awareness about measuring blood pressure at home starting at the age of 18 to raise awareness about measuring blood pressure at home starting at the age of 18. The lack of specific guidelines on the right age to begin blood pressure screening has led to neglect in initiating checks, leaving many individuals vulnerable to hypertension and its complications.

In response to this critical issue, Glenmark initiated discussions with 94 cardiologists across India, leading to a unanimous consensus that 18 is the ideal age to commence blood pressure screening. This expert consensus statement was published in the Journal of the Association of Physicians of India (JAPI) in 2020. The "Take Charge 18" initiative by Glenmark and OMRON Healthcare India consists of generating effective communication to raise awareness about the cause by incorporating an inlay card into every OMRON blood pressure monitor sold in India. The message emphasises the significance of starting blood pressure screening at the appropriate age, which is 18 years. The goal is to encourage patients and carers who come across this inlay card to sensitise at least four family members aged 18 and up to begin monitoring their blood pressure and incorporating it into their health regimen.

This message will also be seamlessly integrated into the OMRON Connect app, ensuring that it reaches all of the company's subscribers, as well as on OMRON's social media and websites. The impact of this awareness campaign will be extended further by reaching out to around 92,000 healthcare professionals (HCPs). This broader approach aims to further foster early screening of blood pressure and create a wider impact on hypertension awareness. If regular blood pressure monitoring can start at early age, it can have a substantial long-term impact on overall health of individuals. A recent spike in cases of heart attack among young Indians is a worrisome trend. Awareness about comprehensive hypertension management and data monitoring can be of great help in managing and preventing such cardiovascular events in near future.

© 2024 India Pharma Outlook. All Rights Reserved.